{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:14:54Z","timestamp":1760346894399,"version":"build-2065373602"},"reference-count":17,"publisher":"Journal of Biological Methods","issue":"1","license":[{"start":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T00:00:00Z","timestamp":1742688000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HPR"],"abstract":"<jats:p>Background\nCognitive impairments, prevalent in 75-80% of schizophrenia patients, severely impact rehabilitation and quality of life. Current therapies, including antipsychotics, have limited success in addressing these deficits. Virtual reality (VR) offers a promising avenue for cognitive training by providing realistic, interactive scenarios for skill application.\n&amp;nbsp;\nObjective\nThis study evaluates the efficacy of a novel VR-based cognitive training intervention in improving cognitive deficits in schizophrenia compared to standard treatment as usual (TAU).\n&amp;nbsp;\nMethods\nA randomized clinical trial was conducted with 16 inpatients diagnosed with schizophrenia. Participants were allocated to either a VR intervention group, receiving six weekly sessions of VR cognitive training, or a control group undergoing TAU. Pre- and post-intervention assessments included the Trail Making Test, Positive and Negative Syndrome Scale, Frontal Assessment Battery, and Tower of London test. Two VR scenarios, &amp;ldquo;Supermarket&amp;rdquo; and &amp;ldquo;Beach,&amp;rdquo; were developed to target working memory, attention, and executive functioning. Data were analyzed using t-tests and linear mixed-effects models.\n&amp;nbsp;\nResults\nThe VR intervention group showed significant improvements in frontal lobe functioning as measured by the Frontal Assessment Battery (FAB) and trends toward better executive function and attention. Scenario-specific analyses revealed reduced errors, omissions, and execution times across sessions. However, broader cognitive and psychiatric symptom improvements were limited and did not persist after multiple-comparison corrections.\n&amp;nbsp;\nConclusion\nVR cognitive training shows potential as an innovative tool for enhancing executive functioning in schizophrenia patients. While immediate task performance improved, broader cognitive impacts and psychiatric symptom reductions were minimal. Future research should focus on long-term efficacy, functional outcomes, and scalability of VR interventions.<\/jats:p>","DOI":"10.52965\/001c.129550","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T13:59:12Z","timestamp":1742738352000},"page":"1","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of cognitive deficits in schizophrenia using a new technique of Cognitive Training in Virtual Reality: a pilot study"],"prefix":"10.14440","volume":"13","author":[{"given":"Emanuele","family":"Bisso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Caponnetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Auditore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Pulvirenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Aguglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Avincola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulnaser","family":"Fakhrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Salvina Signorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5574","published-online":{"date-parts":[[2025,3,23]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/arclin\/acr005","article-title":"Normative Data for Rey's Auditory Verbal Learning Test in Individuals with Schizophrenia","volume":"26","author":"J. C. Badcock","year":"2011","journal-title":"Archives of Clinical Neuropsychology"},{"issue":"3","key":"ref2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/yco.0000000000000925","article-title":"Evidence-based psychosocial interventions in schizophrenia: a critical review","volume":"37","author":"S. Barlati","year":"2024","journal-title":"Current Opinion in Psychiatry"},{"issue":"17","key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17176111","article-title":"Immersive Virtual Reality Applications in Schizophrenia Spectrum Therapy: A Systematic Review","volume":"17","author":"E. Bisso","year":"2020","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"6","key":"ref4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1176\/appi.ajp.2008.08060806","article-title":"Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)","volume":"166","author":"M. Davidson","year":"2009","journal-title":"American journal of psychiatry"},{"issue":"11","key":"ref5","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/wnl.55.11.1621","article-title":"The FAB","volume":"55","author":"B. Dubois","year":"2000","journal-title":"Neurology"},{"issue":"8","key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031606","article-title":"Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange)","volume":"9","author":"D. Freeman","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia","volume":"13","author":"S. R. Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"issue":"1-3","key":"ref8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.schres.2016.03.038","article-title":"Validation of a Computerized test of Functional Capacity","volume":"175","author":"R. S. E. Keefe","year":"2016","journal-title":"Schizophrenia Research"},{"issue":"2","key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/computers13020042","article-title":"Application of Immersive VR Serious Games in the Treatment of Schizophrenia Negative Symptoms","volume":"13","author":"B. Miranda","year":"2024","journal-title":"Computers"},{"issue":"7","key":"ref10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/hup.865","article-title":"Treatment with amisulpride and olanzapine improve neuropsychological function in schizophrenia","volume":"22","author":"A. M. Mortimer","year":"2007","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"issue":"3","key":"ref11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.31887\/DCNS.2010.12.3\/areichenberg","article-title":"The assessment of neuropsychological functioning in schizophrenia","volume":"12","author":"A. Reichenberg","year":"2022","journal-title":"Dialogues in clinical neuroscience"},{"issue":"3","key":"ref12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the Trail Making Test as an Indicator of Organic Brain Damage","volume":"8","author":"R. M. Reitan","year":"2016","journal-title":"Perceptual and Motor Skills"},{"issue":"1-3","key":"ref13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.schres.2014.06.024","article-title":"Motivational deficits in individuals at-risk for psychosis and across the course of schizophrenia","volume":"158","author":"D. A. Schlosser","year":"2014","journal-title":"Schizophrenia Research"},{"issue":"2","key":"ref14","doi-asserted-by":"publisher","DOI":"10.2196\/28502","article-title":"Feasibility and Efficacy of Virtual Reality Interventions to Improve Psychosocial Functioning in Psychosis: Systematic Review","volume":"9","author":"A. H. Schroeder","year":"2022","journal-title":"JMIR Mental Health"},{"issue":"1089","key":"ref15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1098\/rstb.1982.0082","article-title":"Specific impairments of planning","volume":"298","author":"T. Shallice","year":"1997","journal-title":"Philosophical Transactions of the Royal Society of London. B, Biological Sciences"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1022278","article-title":"Virtual-reality-based social cognition and interaction training for patients with schizophrenia: A preliminary efficacy study","volume":"13","author":"Z.-H. Shen","year":"2022","journal-title":"Frontiers in Psychiatry"},{"issue":"3","key":"ref17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1017\/s146114570500516x","article-title":"A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia","volume":"8","author":"N. D. Woodward","year":"2005","journal-title":"The International Journal of Neuropsychopharmacology"}],"container-title":["Health Psychology Research"],"original-title":[],"link":[{"URL":"https:\/\/api.healthpr.org\/uploads\/file\/asp\/20250331172812d33899747.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.healthpr.org\/uploads\/file\/asp\/20250331172812d33899747.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T08:36:15Z","timestamp":1760344575000},"score":1,"resource":{"primary":{"URL":"https:\/\/healthpr.org\/journal\/HPR\/13\/1\/10.52965\/001c.129550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,23]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,6]]}},"URL":"https:\/\/doi.org\/10.52965\/001c.129550","relation":{},"ISSN":["2420-8124"],"issn-type":[{"type":"electronic","value":"2420-8124"}],"subject":[],"published":{"date-parts":[[2025,3,23]]}}}